Literature DB >> 17036378

Heavy smoking and liver.

Abdel-Rahman El-Zayadi1.   

Abstract

Smoking causes a variety of adverse effects on organs that have no direct contact with the smoke itself such as the liver. It induces three major adverse effects on the liver: direct or indirect toxic effects, immunological effects and oncogenic effects. Smoking yields chemical substances with cytotoxic potential which increase necro-inflammation and fibrosis. In addition, smoking increases the production of pro-inflammatory cytokines (IL-1, IL-6 and TNF- alpha) that would be involved in liver cell injury. It contributes to the development of secondary polycythemia and in turn to increased red cell mass and turnover which might be a contributing factor to secondary iron overload disease promoting oxidative stress of hepatocytes. Increased red cell mass and turnover are associated with increased purine catabolism which promotes excessive production of uric acid. Smoking affects both cell-mediated and humoral immune responses by blocking lymphocyte proliferation and inducing apoptosis of lymphocytes. Smoking also increases serum and hepatic iron which induce oxidative stress and lipid peroxidation that lead to activation of stellate cells and development of fibrosis. Smoking yields chemicals with oncogenic potential that increase the risk of hepatocellular carcinoma (HCC) in patients with viral hepatitis and are independent of viral infection as well. Tobacco smoking has been associated with suppression of p53 (tumour suppressor gene). In addition, smoking causes suppression of T-cell responses and is associated with decreased surveillance for tumour cells. Moreover, it has been reported that heavy smoking affects the sustained virological response to interferon (IFN) therapy in hepatitis C patients which can be improved by repeated phlebotomy. Smoker's syndrome is a clinico-pathological condition where patients complain of episodes of facial flushing, warmth of the palms and soles of feet, throbbing headache, fullness in the head, dizziness, lethargy, prickling sensation, pruritus and arthralgia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17036378      PMCID: PMC4088100          DOI: 10.3748/wjg.v12.i38.6098

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  37 in total

Review 1.  Iron toxicity and oxygen radicals.

Authors:  J M Gutteridge; B Halliwell
Journal:  Baillieres Clin Haematol       Date:  1989-04

2.  Cigarette smoking and hepatic lesions in patients with chronic hepatitis C.

Authors:  F Pessione; M J Ramond; C Njapoum; V Duchatelle; C Degott; S Erlinger; B Rueff; D C Valla; F Degos
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

3.  Predictors for development of hyperuricemia: an 8-year longitudinal study in middle-aged Japanese men.

Authors:  N Nakanishi; H Yoshida; K Nakamura; K Suzuki; K Tatara
Journal:  Metabolism       Date:  2001-06       Impact factor: 8.694

Review 4.  Inhalation injuries.

Authors:  D M Heimbach; J F Waeckerle
Journal:  Ann Emerg Med       Date:  1988-12       Impact factor: 5.721

5.  Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study.

Authors:  Silvia Fargion; Anna Ludovica Fracanzani; Angelo Rossini; Mauro Borzio; Oliviero Riggio; Giovanni Belloni; Franco Bissoli; Roberto Ceriani; Marco Ballarè; Marco Massari; Caterina Trischitta; Pierluigi Fiore; Anna Orlandi; Lorenzo Morini; Michela Mattioli; Silvia Oldani; Bruno Cesana; Gemino Fiorelli
Journal:  Am J Gastroenterol       Date:  2002-05       Impact factor: 10.864

6.  Heavy cigarette smoking induces hypoxic polycythemia (erythrocytosis) and hyperuricemia in chronic hepatitis C patients with reversal of clinical symptoms and laboratory parameters with therapeutic phlebotomy.

Authors:  Abdel-Rahman El-Zayadi; Osaima Selim; Hassan Hamdy; Ahmed El-Tawil; Hanaa Moustafa
Journal:  Am J Gastroenterol       Date:  2002-05       Impact factor: 10.864

7.  Impact of cigarette smoking on response to interferon therapy in chronic hepatitis C Egyptian patients.

Authors:  A El-Zayadi; Osaima Selim; H Hamdy; A El-Tawil; Hanaa-M Badran; M Attia; A Saeed
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

8.  Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan.

Authors:  Li-Yu Wang; San-Lin You; Sheng-Nan Lu; Hsi-Chang Ho; Mei-Hui Wu; Chien-An Sun; Hwai-I Yang; Chen Chien-Jen
Journal:  Cancer Causes Control       Date:  2003-04       Impact factor: 2.506

9.  Smoking and liver cancer in China: case-control comparison of 36,000 liver cancer deaths vs. 17,000 cirrhosis deaths.

Authors:  Zheng-Ming Chen; Bo-Qi Liu; Jillian Boreham; Ya-Ping Wu; Jun-Shi Chen; Richard Peto
Journal:  Int J Cancer       Date:  2003-10-20       Impact factor: 7.396

10.  Immune response in asymptomatic smokers.

Authors:  A Zeidel; B Beilin; I Yardeni; E Mayburd; G Smirnov; H Bessler
Journal:  Acta Anaesthesiol Scand       Date:  2002-09       Impact factor: 2.105

View more
  47 in total

1.  Smoking and Liver Disease.

Authors:  Stephanie M Rutledge; Amon Asgharpour
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-12

2.  CCL5-28, CCL5-403, and CCR5 genetic polymorphisms and their synergic effect with alcohol and tobacco consumptions increase susceptibility to hepatocellular carcinoma.

Authors:  Hsiu-Ting Tsai; Shun-Fa Yang; Dar-Ren Chen; Szu-Erh Chan
Journal:  Med Oncol       Date:  2012-02-29       Impact factor: 3.064

Review 3.  Binge drinking: Burden of liver disease and beyond.

Authors:  Susana Llerena; María Teresa Arias-Loste; Angela Puente; Joaquín Cabezas; Javier Crespo; Emilio Fábrega
Journal:  World J Hepatol       Date:  2015-11-28

4.  Agmatine protects rat liver from nicotine-induced hepatic damage via antioxidative, antiapoptotic, and antifibrotic pathways.

Authors:  Nagla A El-Sherbeeny; Manar A Nader; Ghalia M Attia; Hayam Ateyya
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-09-16       Impact factor: 3.000

5.  Risk Assessment of Hepatocellular Carcinoma in General Population by Liver Stiffness in Combination with Controlled Attenuation Parameter using Transient Elastography: A Cross Sectional Study.

Authors:  Takaaki Sugihara; Masahiko Koda; Tomomitsu Matono; Kinya Okamoto; Yoshikazu Murawaki; Hajime Isomoto; Shiho Tokunaga
Journal:  Yonago Acta Med       Date:  2017-06-26       Impact factor: 1.641

6.  Clearing the smoke in chronic liver diseases.

Authors:  Claudia O Zein
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

7.  New insights on non-B non-C hepatocellular carcinoma in mid Delta Region, Egypt.

Authors:  Abdel Raouf Abou El Azm; Mohamed Yousef; Nagwa Mansour; Aymen Awad; Samia El Dardiry; Ibrahim Abdel Aziz
Journal:  J Gastrointest Cancer       Date:  2014-09

8.  Frequency of alcohol and smoking cessation counseling in hepatitis C patients among internists and gastroenterologists.

Authors:  Tanu Chandra; Mary Reyes; Huy Nguyen; Marie Borum
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

9.  Ethanol and tobacco smoke increase hepatic steatosis and hypoxia in the hypercholesterolemic apoE(-/-) mouse: implications for a "multihit" hypothesis of fatty liver disease.

Authors:  Shannon M Bailey; Sudheer K Mantena; Telisha Millender-Swain; Yavuz Cakir; Nirag C Jhala; David Chhieng; Kent E Pinkerton; Scott W Ballinger
Journal:  Free Radic Biol Med       Date:  2009-04-01       Impact factor: 7.376

Review 10.  Novel interactions of mitochondria and reactive oxygen/nitrogen species in alcohol mediated liver disease.

Authors:  Sudheer K Mantena; Adrienne L King; Kelly K Andringa; Aimee Landar; Victor Darley-Usmar; Shannon M Bailey
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.